Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of
consensus on which factors most influence adherence behaviour and methodological …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Non-adherence is a major problem in the treatment of schizophrenia. Its high prevalence,
potentially severe consequences and associated costs make the study of this phenomenon …

Adherence is defined as the extent to which a patient's behavior coincides with medical or
prescribed health advice. Adherence is considered non-judgmental and is preferred over …

ObjectiveNonadherence to antipsychotic medication is highly prevalent in patients with
schizophrenia and has a deleterious impact on the course of the illness. This review seeks …

The definition and assessment of adherence vary considerably across studies. Increasing
consensus regarding these issues is necessary to improve our understanding of adherence …

Among outpatients with schizophrenia, antipsychotic non-adherence is common, grossly
under-detected by patients and their prescribers, and is associated with poor clinical …

Objective: To evaluate predictors of treatment discontinuation against medical advice and
poor medication adherence among first-episode patients treated with olanzapine …

It has remained unclear what factors relate to primary nonadherence to antipsychotic
treatment and whether specific agents and routes of administration differ in how patients …